EquityZen Growth Technology Fund LLC - Series 2212
Raised
$154K
Investors
11
Min Invest
$10,010
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2212 is a Delaware-based pooled investment fund filed by EquityZen Advisors LLC that raised $154K from 11 investors under Rule 506(b) and Section 3(c)(1) exemptions, with a $10K minimum investment. This is part of the EquityZen platform, which operates 1,889 related pre-IPO investment vehicles focused on secondary market access to private growth-stage companies.
This pre-IPO fund follows the standard EquityZen SPV model: small-scale pooled vehicles (typically under $1M) using 506(b) private placement exemptions with accessible minimums ($10K–$25K range) to aggregate investor capital for secondary purchases of shares in specific private companies. The dual exemption claim (506(b) + 3(c)(1)) and low minimum investment are consistent with platform convention across the EquityZen entity family.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
